Fasching, Peter A. http://orcid.org/0000-0003-4885-8471
Gass, Paul
Häberle, Lothar
Volz, Bernhard
Hein, Alexander
Hack, Carolin C.
Lux, Michael P.
Jud, Sebastian M.
Hartmann, Arndt
Beckmann, Matthias W.
Slamon, Dennis J.
Erber, Ramona
Article History
Received: 12 December 2018
Accepted: 6 March 2019
First Online: 13 March 2019
Compliance with ethical standards
:
: AH has received honoraria from Roche, Janssen, Merck Sharp Dome, AstraZeneca, Novartis, Cepheid, Abbvie and Boehringer-Ingelheim. His institution performs research with Grants from Biontech, Janssen, Cepheid, Roche and Qiagen. DJS has received honoraria from Novartis, Pfizer and Lilly and owns stock in Pfizer, Amgen and Seattle Genetics. His institution performs research with Grants from Novartis. PAF has received honoraria from Novartis, Amgen, Pfizer, Roche, Teva, Celgene, Eisai, Daiichi-Sankyo and PUMA. His institution performs research with Grants from Biontech and Novartis. PG has received honoraria from Novartis, travel support from Novartis, Roche and PharmaMar. MPL has received honoraria from Novartis, AstraZeneca, Roche, Pfizer, Lilly Eisai, Genomic Health and Tesaro. The remaining authors declare that they have no conflict of interest.
: Approval for this retrospective study was obtained from the Ethics Committee of the Faculty of Medicine at Friedrich Alexander University of Erlangen-Nuremberg. All procedures were in accordance with the Ethical Standards of the Institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from each individual participant included in the study.